Another delay for Bristol Myers cell therapy as FDA extends review

Submitted by admin on May 6, 2020 - 12:21pm

Source:

BioPharma Dive

News Tags:

FDA

Bristol-Myers Squibb

liso-cell

cancer

cell therapy

Headline:

Another delay for Bristol Myers cell therapy as FDA extends review

snippet:

The Food and Drug Administration has extended its review of Bristol Myers Squibb's cancer cell therapy liso-cel by three months after receiving new information it requested from the company.

Search form

You are here

Another delay for Bristol Myers cell therapy as FDA extends review

Another delay for Bristol Myers cell therapy as FDA extends review